Literature DB >> 24126614

B-cell memory and primary immune deficiencies: interleukin-21 related defects.

Marylin Desjardins1, Bruce D Mazer.   

Abstract

PURPOSE OF REVIEW: The purpose of this study is to describe recent advances in our understanding of the role of interleukin-21 (IL-21) in B-cell maturation, and how defects in IL-21 receptor (IL-21R) signalling pathways (IL-21R/γc/JAK3/STAT3) are related to primary immune deficiencies. RECENT
FINDINGS: Abnormal signalling through IL-21R/γc/JAK3/STAT3 pathway has been related to decreased specific antibody responses following vaccination, and to increased susceptibility to encapsulated bacterial infections. This is manifested in the hyper-IgE syndrome, X-linked and JAK3-related severe combined immunodeficiency (SCID) and loss-of-function mutations in the IL-21R gene. Common variable immunodeficiency is associated with impaired in-vitro development of peripheral blood mononuclear cells or purified B-cells into memory or CD38 B-cells following addition of IL-21.
SUMMARY: IL-21 is a key cytokine in development of B-cells into immunoglobulin-secreting cells. Abnormal signalling through the IL-21R/γc/JAK3/STAT3 pathway leads to defective humoral immune responses to both T-dependent and T-independent antigens and impairs the establishment of long-lasting B-cell memory. Studies involving patients with hyper-IgE syndrome demonstrated the nonredundant role of STAT3 in B-cell production of high-affinity specific antibodies, while total serum immunoglobulins could be maintained through STAT3-independent activation of AID (activation-induced cytidine-deaminase). IL-21 related defects may also be associated with reduced natural killer (NK)-cell cytotoxicity and TH17 cytokine production, indicating that abnormalities in the IL-21-IL-21R pathway have profound effects on crucial immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126614     DOI: 10.1097/ACI.0000000000000009

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  11 in total

1.  Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Authors:  Yongyin Li; Weibin Wang; Libo Tang; Xuanqiu He; Xin Yan; Xiaoyong Zhang; Youfu Zhu; Jian Sun; Yongquan Shi; Xiong Ma; Ian R Mackay; M Eric Gershwin; Ying Han; Jinlin Hou
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

Review 2.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.

Authors:  Stephanie Albin; Charlotte Cunningham-Rundles
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

3.  Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody.

Authors:  L Xue; T Hickling; R Song; J Nowak; B Rup
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

4.  Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.

Authors:  Marylin Desjardins; Marianne Béland; Marieme Dembele; Duncan Lejtenyi; Jean-Phillipe Drolet; Martine Lemire; Christos Tsoukas; Moshe Ben-Shoshan; Francisco J D Noya; Reza Alizadehfar; Christine T McCusker; Bruce D Mazer
Journal:  J Clin Immunol       Date:  2017-11-04       Impact factor: 8.317

5.  TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis.

Authors:  Yong Zhang; Zhen Shao; Xiuying Zhang; Xiao Jia; Yan Xia; Yanyan Zhang; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Ruiguo Dong; Chenghua Xiao; Deqin Geng; Yonghai Liu
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-24       Impact factor: 4.147

6.  Mining 3D genome structure populations identifies major factors governing the stability of regulatory communities.

Authors:  Chao Dai; Wenyuan Li; Harianto Tjong; Shengli Hao; Yonggang Zhou; Qingjiao Li; Lin Chen; Bing Zhu; Frank Alber; Xianghong Jasmine Zhou
Journal:  Nat Commun       Date:  2016-05-31       Impact factor: 14.919

7.  Potential immunosuppressive effects of Escherichia coli O157:H7 experimental infection on the bovine host.

Authors:  E Kieckens; J Rybarczyk; R W Li; D Vanrompay; E Cox
Journal:  BMC Genomics       Date:  2016-12-21       Impact factor: 3.969

8.  IL-21 and anti-CD40 restore Bcl-2 family protein imbalance in vitro in low-survival CD27+ B cells from CVID patients.

Authors:  Antonio López-Gómez; Antonio Clemente; Vanesa Cunill; Jaime Pons; Joana M Ferrer
Journal:  Cell Death Dis       Date:  2018-11-21       Impact factor: 8.469

9.  A Unique Heterozygous CARD11 Mutation Combines Pathogenic Features of Both Gain- and Loss-of-Function Patients in a Four-Generation Family.

Authors:  Marylin Desjardins; Swadhinya Arjunaraja; Jeffrey R Stinson; Batsukh Dorjbal; Janani Sundaresan; Julie Niemela; Mark Raffeld; Helen F Matthews; Angela Wang; Pamela Angelus; Helen C Su; Bruce D Mazer; Andrew L Snow
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

Review 10.  Essential Kinases and Transcriptional Regulators and Their Roles in Autoimmunity.

Authors:  Ya Nan Deng; Joseph A Bellanti; Song Guo Zheng
Journal:  Biomolecules       Date:  2019-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.